The research on dendritic cell vaccines is ongoing, with numerous clinical trials being conducted to evaluate their efficacy and safety. These trials aim to refine the vaccine formulation, dosing, and administration methods. Preliminary results have shown promise, but more extensive studies are needed to confirm their benefits and determine the best practices for their use in clinical settings.
